![]() | ![]() |
Formats:
|
||||||||||||||||||||||||
Copyright © 2006, American Society for Microbiology Fbxw8 Is Essential for Cul1-Cul7 Complex Formation and for Placental Development Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582,1 CREST, Japan Science and Technology Agency, Kawaguchi, Saitama 332-0012,Japan2 *Corresponding author. Mailing address: Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. Phone: 81-92-642-6815. Fax: 81-92-642-6819. E-mail: nakayak1/at/bioreg.kyushu-u.ac.jp. Received April 6, 2006; Revised May 22, 2006; Accepted June 6, 2006. This article has been cited by other articles in PMC.Abstract Cullin-based ubiquitin ligases (E3s) constitute one of the largest E3 families. Fbxw8 (also known as Fbw6 or Fbx29) is an F-box protein that is assembled with Cul7 in an SCF-like E3 complex. Here we show that Cul7 forms a heterodimeric complex with Cul1 in a manner dependent on Fbxw8. We generated mice deficient in Fbxw8 and found that Cul7 did not associate with Cul1 in cells of these mice. Two-thirds of Fbxw8−/− embryos die in utero, whereas the remaining one-third are born alive and grow to adulthood. Fbxw8−/− embryos show intrauterine growth retardation and abnormal development of the placenta, characterized by both a reduced thickness of the spongiotrophoblast layer and abnormal vessel structure in the labyrinth layer. Although the placental phenotype of Fbxw8−/− mice resembles that of Cul7−/− mice, other abnormalities of Cul7−/− mice are not apparent in Fbxw8−/− mice. These results suggest that the Cul7-based SCF-like E3 complex has both Fbxw8-dependent and Fbxw8-independent functions. Ubiquitin-dependent proteolysis plays indispensable roles in various biological processes (6, 17, 38). Protein ubiquitylation is mediated by several enzymes that act in concert. A ubiquitin-activating enzyme (E1), with ATP as a substrate, catalyzes the formation of a thioester bond between itself and ubiquitin, and it then transfers the activated ubiquitin to a ubiquitin-conjugating enzyme (E2). Certain E2 enzymes transfer ubiquitin directly to the protein substrate, whereas others require the participation of a third component, a ubiquitin ligase (E3), to achieve this effect (16). Hundreds of E3s have been identified in eukaryotes and classified into three groups: HECT-type, U-box-type, and RING-type E3s. Cullin-based E3s, a subtype of RING-type E3s, are multisubunit complexes (13, 30). To date, seven mammalian proteins, Cul1, Cul2, Cul3, Cul4A, Cul4B, Cul5, and Cul7, have been identified as members of the cullin family. These proteins interact via their COOH-terminal cullin homology domain with Rbx1 or Rbx2, each of which contains a RING finger domain that interacts with E2. They also interact via their NH2-terminal cullin repeat (with or without the participation of an adapter molecule such as Skp1 or Elongin C) with substrate recognition molecules, such as F-box proteins in the Cul1-based SCF complex (7, 20, 23, 28, 39), VHL-box proteins in the Cul2-based ECV complex (22), BTB domain proteins in the Cul3-based E3 complex (12, 31, 40), and SOCS-box proteins in the Cul5-based ECS complex (22). At least two other molecules, the APC2 subunit of the anaphase-promoting complex/cyclosome and the Cul7-related protein Parc, also possess a cullin homology domain (30, 34). Cul7 was originally identified as p185, a protein that binds the large T antigen of simian virus 40 (24). The interaction of p185 with large T antigen is important for the cellular transformation activity of the latter (2), and the BH3 domain identified in the COOH-terminal region of p185 is thought to function in the promotion of apoptosis (36). More recently, p185 was isolated as a protein that binds Rbx1 and which contains a COOH-terminal cullin homology domain; it was thus named Cul7 (11). Cul7 possesses ubiquitylation activity in vitro and interacts with the F-box protein Fbxw8 (also known as Fbw6 or Fbx29), which was identified as a Cul7-binding protein by “pull-down” analysis with Cul7 (11). Fbxw8 is thus not only the receptor component of an SCF (Skp1, Cul1, F-box protein, Rbx1)-type E3 complex but is also the only F-box protein known to interact with Cul7 (4, 11). Cul7 does not interact directly with Skp1 but does so indirectly in an Fbxw8-dependent manner. Fbxw8 appears to interact with Cul7 with a higher affinity than it does with Cul1. Mice deficient in Cul7 exhibit intrauterine growth retardation as a result of abnormal development of the placenta, characterized by impaired formation of the spongiotrophoblast layer and of vessels in the labyrinth layer, and they die from respiratory distress soon after birth (4). In addition, Fbxw8 is unstable, and its expression is reduced to below detectable levels in Cul7−/− cells, with this phenotype being normalized by forced expression of exogenous Cul7. Cul7 is thus thought to play an important role in stabilization of Fbxw8 as well as in the normal development of the placenta and embryo. Cul7 mutations were recently identified in several pedigrees of 3-M syndrome, an autosomal recessive form of hereditary dwarfism characterized by pre- and postnatal growth retardation without mental or endocrine disorders, suggesting that Cul7 is also indispensable for normal human growth (18). It has remained unclear whether Fbxw8 is the only substrate recognition subunit of the Cul7-based SCF-like complex. To reveal the physiological roles of Fbxw8 and its corresponding E3 complexes, we have generated mice deficient in this protein. We now show that the phenotype of Fbxw8−/− mice is similar to that of Cul7−/− mice, especially with regard to growth retardation and placental abnormality. However, other characteristics of Cul7−/− mice are not apparent in Fbxw8−/− mice, suggesting that the Cul7-based SCF-like complex has both Fbxw8-dependent and Fbxw8-independent functions. Moreover, we found that Cul7 forms a complex with Cul1 in an Fbxw8-dependent manner. Our data thus suggest that the newly identified Cul1-Fbxw8-Cul7 complex plays an important role in the normal development of the placenta. MATERIALS AND METHODS Generation of Fbxw8−/− mice. Cloned DNA corresponding to the Fbxw8 locus was amplified from the genome of embryonic day 14 (E14) mouse embryonic stem (ES) cells with the use of LA-Taq polymerase (TaKaRa). The targeting vector was constructed by replacement of a 2.4-kb fragment of genomic DNA containing exon 2 of Fbxw8 with IRES-lacZ and PGK-neo-poly(A)-loxP cassettes (5). The vector thus contained 6.5- and 1.2-kb regions of homology located 5′ and 3′, respectively, relative to IRES-lacZ and the neomycin resistance gene (neo). The diphtheria toxin A (DT-A) cassette was ligated at the 3′ end of the targeting construct. Maintenance, transfection, and selection of ES cells were performed as described previously (26). The recombination event was confirmed by Southern blot analysis with a 0.5-kb fragment of genomic DNA that flanks the 3′ homology region (Fig. (Fig.1A).1A
Antibodies. Polyclonal anti-Fbxw8, anti-Cul7, and anti-Rbx1 antibodies were generated in rabbits with a recombinant COOH-terminal fragment of mouse Fbxw8, a recombinant NH2-terminal fragment of mouse Cul7, and recombinant human full-length Rbx1 produced in Escherichia coli. Polyclonal anti-Cul1 antibodies were obtained from Zymed, monoclonal anti-Skp1 and anti-HSP70 antibodies were from BD Transduction Laboratories, and monoclonal anti-FLAG (M2) antibody was from Sigma. Histological analysis. Tissue was fixed with 4% paraformaldehyde in phosphate-buffered saline, embedded in paraffin, and sectioned at a thickness of 3 μm. Hematoxylin-eosin staining was performed as described previously (27). Sixteen different fields (magnification, ×200) were randomly selected for measurement of the mean areas of maternal and fetal vessels in the placenta with the use of SCION Image software. For immunofluorescence, samples were fixed with 4% paraformaldehyde in phosphate-buffered saline, embedded in OCT compound (Tissue Tek), and sectioned with a cryostat at a thickness of 5 μm. Immunohistofluorescence analysis was performed as described previously (27, 37) with monoclonal anti-PECAM-1 (MEC13.3; PharMingen) and polyclonal anti-cytokeratin (WSS; Dako). Immune complexes were detected with secondary antibodies labeled with Alexa 546 or Alexa 488 (each at a 1:2,000 dilution). The specimens were examined with a fluorescence microscope and photographed. In situ hybridization. Tissue was fixed with 4% paraformaldehyde in phosphate-buffered saline, embedded in paraffin, and sectioned at a thickness of 5 μm. Riboprobes specific for Fbxw8 or Tpbp mRNAs were synthesized with a DIG RNA labeling kit (Roche). In situ hybridization was performed with the Ventana HX system as described previously (37). Sections were counterstained with Nuclear Fast Red (Ventana). Preparation of MEFs. Primary mouse embryonic fibroblasts (MEFs) were obtained from E13.5 embryos and cultured as previously described (26). For biochemical analysis, the cells were plated in 10-cm dishes at a density of 2 × 106 cells per dish. Plasmids, transfection, immunoprecipitation, and immunoblot analysis. Mouse cDNAs for Fbxw5, Fbxw8, and Fbxw8 deletion mutants were subcloned into the p3xFLAG-CMV 7.1 vector (Sigma). HEK293T cells were transfected with the resulting plasmids by the calcium phosphate method and cultured for 48 h before analysis. For retrovirus production, full-length mouse Cul1, Cul2, and Cul7 cDNAs were each subcloned into the pMX-puro II-U6-3xFLAG vector (21). The resulting plasmids were introduced into Plat-E cells by transfection with the Fu-Gene reagent (Roche) to generate recombinant retroviruses. MEFs were infected with the recombinant retroviruses and subjected to selection for 3 days in medium containing puromycin (10 μg/ml). The surviving cells were then isolated, lysed in a solution containing 0.5% Triton X-100, and subjected to immunoprecipitation with anti-FLAG as described previously (15). Embryos, placenta, and adult mouse tissue samples were lysed in radioimmunoprecipitation assay buffer and subjected to immunoprecipitation and immunoblot analysis as described previously (27, 37). RNA interference (RNAi). The pMX-puro II-U6/shRNA vector was constructed as described previously (21). The DNA for the short hairpin RNA (shRNA) encoded a 21-nucleotide hairpin sequence specific to the mRNA target, with a loop sequence (5′-TTCAAGAGA-3′) separating the two complementary domains, and it contained a tract of five T nucleotides to terminate transcription. The hairpin sequences specific for mouse Cul7 (mCul7-1 and mCul7-2) and enhanced green fluorescent protein (EGFP; Clontech) mRNAs corresponded to nucleotides 3022 to 3042 (mCul7-1), 4714 to 4734 (mCul7-2), and 126 to 146 (EGFP) of the respective coding regions. Recombinant retroviruses were produced and used to infect MEFs as described above. After selection in medium containing puromycin (10 μg/ml), cells stably expressing the shRNA were pooled for experiments. RESULTS To elucidate the physiological functions of Fbxw8, we generated mice deficient in this protein. The Fbxw8 gene was disrupted in mouse embryonic stem cells by replacement of exon 2, which encodes the NH2 terminus of Fbxw8, with IRES-lacZ and PGK-neo-poly(A)-loxP cassettes (Fig. (Fig.1A).1A
Immunoblot analysis of wild-type mice with antibodies to Fbxw8 also revealed that Fbxw8 was more abundant in the placenta than in the embryo at embryonic day 13.5 (Fig. (Fig.1C),1C We examined embryos from Fbxw8+/− intercrosses at various developmental stages to determine the time at which Fbxw8−/− embryos become abnormal. All Fbxw8−/− embryos were still recoverable at E11.5, whereas some of them were already dead or had begun to degenerate by E12.5 (Table 1). The number of live Fbxw8−/− embryos was reduced to about one-half of that of wild-type littermates by E15.5. Growth retardation of homozygous mutant embryos and a reduction in size of the corresponding placentas were also apparent as early as E12.5 but became more obvious at later stages of gestation (Fig. (Fig.2A).2A
Given that Cul7−/− neonates die soon after birth from respiratory failure as a result of a failure of the lungs to inflate (4), we examined the lungs of Fbxw8−/− fetuses at E19.5. The lungs of the mutant fetuses inflated as well as did those of their wild-type littermates (data not shown), suggesting that the lung phenotype of Cul7−/− mice is independent of Fbxw8. We also examined the proliferation of MEFs prepared from E13.5 embryos and did not find any substantial difference between the Fbxw8−/− and wild-type cells, although the growth of the mutant MEFs tended to be slightly slower than that of the Fbxw8+/+ cells (data not shown). MEFs derived from Cul7−/− embryos exhibit a significant growth defect in culture (4). The placenta of Fbxw8−/− embryos is grossly abnormal (Fig. (Fig.2A).2A
Vessels in the labyrinth layer are also abnormal in Cul7−/− mice (4). We measured the areas of maternal and fetal vessels in the labyrinth layer of the placenta of wild-type and Fbxw8−/− embryos. Maternal and fetal vessels were distinguished from each other on the basis of the presence of nucleated (fetal) or denucleated (maternal) red blood cells. Similar to Cul7−/− mice, the maternal vessel area of the Fbxw8−/− placenta was significantly smaller than that of the wild-type placenta (Fig. (Fig.3E).3E To investigate whether the maternal Fbxw8 mutation affected the placental phenotype of Fbxw8−/− embryos, we compared crosses of Fbxw8+/− females and Fbxw8+/− males with those of Fbxw8−/− females and Fbxw8+/− males (Fig. (Fig.5).5
Fbxw8 contains an F-box domain in its NH2-terminal region and five WD40 domains in its central and COOH-terminal regions (Fig. (Fig.6C).6C
The abundance of Cul7 appeared normal in the placenta of Fbxw8−/− embryos (Fig. (Fig.6A),6A We investigated the regions of Fbxw8 that mediate the interactions with Cul1 and Cul7 by generating a series of deletion mutants of Fbxw8 tagged at their NH2 termini with the 3× FLAG epitope (Fig. (Fig.6C).6C Given that Fbxw8 interacts with both Cul1 and Cul7, we hypothesized that a single Fbxw8 molecule might bind to both Cul1 and Cul7 simultaneously. To test this hypothesis, we expressed 3× FLAG-tagged Cul1 in Fbxw8+/+ or Fbxw8−/− MEFs and then subjected cell lysates to coimmunoprecipitation analysis with anti-FLAG (Fig. (Fig.7A).7A
DISCUSSION Whereas the Cul1-based SCF complex has been extensively characterized, the structure and functions of the Cul7-based SCF-like complex have remained largely unknown. Compared with that of other cullins, the structure of Cul7 seems atypical. Whereas other cullins contain a binding domain for adapter proteins (such as Skp1 or Elongin C) juxtaposed NH2 terminal to the cullin homology domain, Cul7 possesses a large region of unknown function NH2 terminal to the cullin homology domain, except for a DOC domain at its central region. Immunoprecipitation and mass spectrometric analyses have revealed that the F-box protein Fbxw8 is present in the Cul7-based SCF-like complex (4, 11), although it has remained unknown whether Fbxw8 is the only substrate recognition subunit of this complex. Our genetic analysis now indicates that Cul7 has Fbxw8-independent functions, suggesting the existence of other such substrate recognition subunits (see below). Unexpectedly, we found that the F-box domain of Fbxw8 is not necessary for the interaction with Cul7, whereas it is required for the binding of Fbxw8 to Cul1. This finding is consistent with the previous observation that Skp1 is not necessary for the interaction between Cul7 and Fbxw8 (4, 11). These data thus indicate that Fbxw8 interacts with Cul7 in a manner independent of both the F-box domain and Skp1. Our binding data suggest that Cul7 associates directly or indirectly with the central and COOH-terminal regions of Fbxw8. The difference in the binding sites of Fbxw8 for Cul1 and Cul7 suggested the possibility that a Cul1-Fbxw8-Cul7 complex might form in cells. We have now demonstrated that such a complex indeed exists in wild-type cells, whereas Cul1 and Cul7 do not interact in Fbxw8−/− cells. We thus propose that Fbxw8 functions, at least in part, as a linker to tether Cul1 and Cul7 (Fig. (Fig.88 Fbxw8 is unstable and undetectable in Cul7−/− mice (4). We have now shown that Fbxw8 is also undetectable in MEFs depleted of Cul7 by RNAi, suggesting that Cul7 plays a chaperone-like role in stabilizing Fbxw8 through formation of a stable Cul1-Fbxw8-Cul7 complex. In contrast, Cul7 expression was unaffected by the loss of Fbxw8 in the present study. The phenotype of Cul7−/− mice thus likely reflects the loss of Fbxw8 function as well as the loss of Cul7 function that is independent of Fbxw8 (Fig. (Fig.88 The Cul1-Fbxw8-Cul7 complex is likely to contain at least two molecules of Rbx1, which is thought to associate directly with the E2 Cdc34. To date, several types of E3 or E3 complex are known to contain two RING finger domains for E2 binding. For example, Parkin contains two RING finger domains (19, 29, 34), both of which are indispensable for its E3 activity (19). BRCA1 and BARD1, both of which contain a single RING finger domain, dimerize to exert E3 activity (14). These observations suggest that two RING finger domains might also be required for maximal activation of E3 activity in the Cul1-Fbxw8-Cul7 complex. In 3-M syndrome patients who harbor mutations in Cul7, some mutations are located in the exon that encodes the cullin homology domain and result in impaired binding to Rbx1 (18). In addition, F-box proteins such as mammalian β-TrCP1 and β-TrCP2 and Schizosaccharomyces pombe Pop1p and Pop2p form homo- or heterodimers to achieve efficient ubiquitylation of their substrate proteins or to generate combinatorial diversity (25, 33, 35), suggesting the possibility that Cul1 incorporated in the SCF complex might form a dimer through dimerization of F-box proteins. Cul7 also forms a dimer with the related protein Parc (34). These data suggest that cullin-based E3s generally exist as homo- or heterodimeric complexes. The expression of Fbxw8 is largely restricted to the placenta, whereas Cul7 is expressed not only in the embryo and the placenta but also in various tissues of adult mice and humans (18, 36). A comparison of the phenotypes of Fbxw8−/− mice (this study) and Cul7−/− mice (4) is summarized in Table 2. Consistent with the tissue distributions of these proteins, the abnormalities in Fbxw8−/− mice appear to be restricted to the placenta, whereas those in Cul7−/− mice also involve other tissues. Both types of mice manifest abnormal development of the spongiotrophoblast and labyrinth layers of the placenta. During placental development, trophectodermal cells distant from the inner cell mass of the blastocyst stop dividing but undergo endoduplication of their DNA, resulting in the formation of polyploid trophoblast giant cells. Trophectodermal cells overlying the inner cell mass continue to proliferate to form extraembryonic ectoderm and the ectoplacental cone of the early postimplantation conceptus. After chorioallantoic fusion in the mouse at E8.5, chorionic ectodermal cells derived from extraembryonic ectoderm differentiate into syncytiotrophoblasts to form the labyrinth in concert with fetal blood vessels, and ectoplacental cone cells develop into spongiotrophoblasts (1, 8-10, 32). The labyrinth is essential for gas exchange and nutrition transfer between the maternal and fetal circulation (9, 10, 32). Our data now suggest that the Cul1-Fbxw8-Cul7 complex plays an essential role in the mid- to late stage of placental development, and that the embryonic death of Fbxw8−/− mice results from inappropriate development of the placenta. The less severe placental phenotype of Cul7−/− mice, compared with that of Fbxw8−/− mice, might be attributable to residual expression of Fbxw8 in Cul7−/− mice. In contrast, the maternal decidua and trophoblast giant cells appeared unaffected in Fbxw8−/− mice, whereas Cul7−/− mice exhibit a reduced number of trophoblast giant cells and an underdeveloped decidual layer (4), suggesting that Cul7 contributes to the growth of trophoblast giant cells and differentiation of the maternal decidua in an Fbxw8-independent manner.
All Cul7−/− mice die soon after birth from respiratory distress (4). In addition, ~20% of Cul7−/− mice exhibit hypodermal hemorrhage at late gestational ages (4). These phenotypes were not observed in Fbxw8−/− mice, again suggesting that Cul7 has Fbxw8-dependent and -independent functions. The latter functions might be mediated by substrate recognition subunits other than Fbxw8 that associate with Cul7 to form an E3 ligase or by ubiquitylation-independent activity of Cul7. Cul7 was originally identified as a binding partner for the large T antigen of simian virus 40, and it contains a BH3 domain in its COOH-terminal region, implicating Cul7 in cellular transformation and apoptosis (2, 24, 36). The phenotypic differences between Fbxw8−/− mice and Cul7−/− mice are thus likely attributable to the different expression patterns of the corresponding proteins and to Cul7-specific functions not related to Fbxw8-mediated ubiquitylation. Acknowledgments We thank Y. Shinomiya, K. Shinohara, N. Nishimura, R. Mitsuyasu, Y. Yoshimura, and other laboratory members for technical assistance; Y. Yamada for generating knockout mice; and A. Ohta for help in preparation of the manuscript. This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by a research grant from the Human Frontier Science Program. REFERENCES 1. Adamson, S. L., Y. Lu, K. J. Whiteley, D. Holmyard, M. Hemberger, C. Pfarrer, and J. C. Cross. 2002. Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev. Biol. 250:358-373. [PubMed] 2. Ali, S. H., J. S. Kasper, T. Arai, and J. A. DeCaprio. 2004. Cul7/p185/p193 binding to simian virus 40 large T antigen has a role in cellular transformation. J. Virol. 78:2749-2757. [PubMed] 3. Anson-Cartwright, L., K. Dawson, D. Holmyard, S. J. Fisher, R. A. Lazzarini, and J. C. Cross. 2000. The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat. Genet. 25:311-314. [PubMed] 4. Arai, T., J. S. Kasper, J. R. Skaar, S. H. Ali, C. Takahashi, and J. A. DeCaprio. 2003. Targeted disruption of p185/Cul7 gene results in abnormal vascular morphogenesis. Proc. Natl. Acad. Sci. USA 100:9855-9860. [PubMed] 5. Bessho, Y., R. Sakata, S. Komatsu, K. Shiota, S. Yamada, and R. Kageyama. 2001. Dynamic expression and essential functions of Hes7 in somite segmentation. Genes Dev. 15:2642-2647. [PubMed] 6. Cardozo, T., and M. Pagano. 2004. The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell. Biol. 5:739-751. [PubMed] 7. Cenciarelli, C., D. S. Chiaur, D. Guardavaccaro, W. Parks, M. Vidal, and M. Pagano. 1999. Identification of a family of human F-box proteins. Curr. Biol. 9:1177-1179. [PubMed] 8. Cross, J. C. 2005. How to make a placenta: mechanisms of trophoblast cell differentiation in mice-a review. Placenta 26:S3-9. [PubMed] 9. Cross, J. C., D. Baczyk, N. Dobric, M. Hemberger, M. Hughes, D. G. Simmons, H. Yamamoto, and J. C. Kingdom. 2003. Genes, development and evolution of the placenta. Placenta 24:123-130. [PubMed] 10. Cross, J. C., M. Hemberger, Y. Lu, T. Nozaki, K. Whiteley, M. Masutani, and S. L. Adamson. 2002. Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta. Mol. Cell. Endocrinol. 187:207-212. [PubMed] 11. Dias, D. C., G. Dolios, R. Wang, and Z. Q. Pan. 2002. CUL7: a DOC domain-containing cullin selectively binds Skp1.Fbx29 to form an SCF-like complex. Proc. Natl. Acad. Sci. USA 99:16601-16606. [PubMed] 12. Furukawa, M., Y. J. He, C. Borchers, and Y. Xiong. 2003. Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. Nat. Cell Biol. 5:1001-1007. [PubMed] 13. Guardavaccaro, D., and M. Pagano. 2004. Oncogenic aberrations of cullin-dependent ubiquitin ligases. Oncogene 23:2037-2049. [PubMed] 14. Hashizume, R., M. Fukuda, I. Maeda, H. Nishikawa, D. Oyake, Y. Yabuki, H. Ogata, and T. Ohta. 2001. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J. Biol. Chem. 276:14537-14540. [PubMed] 15. Hatakeyama, S., M. Kitagawa, K. Nakayama, M. Shirane, M. Matsumoto, K. Hattori, H. Higashi, H. Nakano, K. Okumura, K. Onoe, R. A. Good, and K. I. Nakayama. 1999. Ubiquitin-dependent degradation of IκBα is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. Proc. Natl. Acad. Sci. USA 96:3859-3863. [PubMed] 16. Hershko, A., and A. Ciechanover. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425-479. [PubMed] 17. Hicke, L. 2001. Protein regulation by monoubiquitin. Nat. Rev. Mol. Cell. Biol. 2:195-201. [PubMed] 18. Huber, C., D. Dias-Santagata, A. Glaser, J. O'Sullivan, R. Brauner, K. Wu, X. Xu, K. Pearce, R. Wang, M. L. Uzielli, N. Dagoneau, W. Chemaitilly, A. Superti-Furga, H. D. Santos, A. Megarbane, G. Morin, G. Gillessen-Kaesbach, R. Hennekam, I. V. Burgt, G. C. Black, P. E. Clayton, A. Read, M. L. Merrer, P. J. Scambler, A. Munnich, Z. Q. Pan, R. Winter, and V. Cormier-Daire. 2005. Identification of mutations in CUL7 in 3-M syndrome. Nat. Genet. 37:1119-1124. [PubMed] 19. Imai, Y., M. Soda, and R. Takahashi. 2000. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem. 275:35661-35664. [PubMed] 20. Jin, J., T. Cardozo, R. C. Lovering, S. J. Elledge, M. Pagano, and J. W. Harper. 2004. Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev. 18:2573-2580. [PubMed] 21. Kamura, T., T. Hara, M. Matsumoto, N. Ishida, F. Okumura, S. Hatakeyama, M. Yoshida, K. Nakayama, and K. I. Nakayama. 2004. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27Kip1 at G1 phase. Nat. Cell Biol. 6:1229-1235. [PubMed] 22. Kamura, T., K. Maenaka, S. Kotoshiba, M. Matsumoto, D. Kohda, R. C. Conaway, J. W. Conaway, and K. I. Nakayama. 2004. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev. 18:3055-3065. [PubMed] 23. Kipreos, E. T., and M. Pagano. 2000. The F-box protein family. Genome Biol. 1:REVIEWS3002. [PubMed] 24. Kohrman, D. C., and M. J. Imperiale. 1992. Simian virus 40 large T antigen stably complexes with a 185-kilodalton host protein. J. Virol. 66:1752-1760. [PubMed] 25. Kominami, K., I. Ochotorena, and T. Toda. 1998. Two F-box/WD-repeat proteins Pop1 and Pop2 form hetero- and homo-complexes together with cullin-1 in the fission yeast SCF (Skp1-Cullin-1-F-box) ubiquitin ligase. Genes Cells 3:721-735. [PubMed] 26. Nakayama, K., N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, D. Y. Loh, and K. I. Nakayama. 1996. Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720. [PubMed] 27. Nakayama, K., H. Nagahama, Y. A. Minamishima, M. Matsumoto, I. Nakamichi, K. Kitagawa, M. Shirane, R. Tsunematsu, T. Tsukiyama, N. Ishida, M. Kitagawa, K. I. Nakayama, and S. Hatakeyama. 2000. Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication. EMBO J. 19:2069-2081. [PubMed] 28. Nakayama, K. I., and K. Nakayama. 2005. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin. Cell Dev. Biol. 16:323-333. [PubMed] 29. Nikolaev, A. Y., M. Li, N. Puskas, J. Qin, and W. Gu. 2003. Parc: a cytoplasmic anchor for p53. Cell 112:29-40. [PubMed] 30. Petroski, M. D., and R. J. Deshaies. 2005. Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell. Biol. 6:9-20. [PubMed] 31. Pintard, L., J. H. Willis, A. Willems, J. L. Johnson, M. Srayko, T. Kurz, S. Glaser, P. E. Mains, M. Tyers, B. Bowerman, and M. Peter. 2003. The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase. Nature 425:311-316. [PubMed] 32. Rossant, J., and J. C. Cross. 2001. Placental development: lessons from mouse mutants. Nat. Rev. Genet. 2:538-548. [PubMed] 33. Seibert, V., C. Prohl, I. Schoultz, E. Rhee, R. Lopez, K. Abderazzaq, C. Zhou, and D. A. Wolf. 2002. Combinatorial diversity of fission yeast SCF ubiquitin ligases by homo- and heterooligomeric assemblies of the F-box proteins Pop1p and Pop2p. BMC Biochem. 3:22. [PubMed] 34. Skaar, J. R., T. Arai, and J. A. Decaprio. 2005. Dimerization of CUL7 and PARC is not required for all CUL7 functions and mouse development. Mol. Cell. Biol. 25:5579-5589. [PubMed] 35. Suzuki, H., T. Chiba, T. Suzuki, T. Fujita, T. Ikenoue, M. Omata, K. Furuichi, H. Shikama, and K. Tanaka. 2000. Homodimer of two F-box proteins βTrCP1 or βTrCP2 binds to IκBα for signal-dependent ubiquitination. J. Biol. Chem. 275:2877-2884. [PubMed] 36. Tsai, S. C., K. B. Pasumarthi, L. Pajak, M. Franklin, B. Patton, H. Wang, W. J. Henzel, J. T. Stults, and L. J. Field. 2000. Simian virus 40 large T antigen binds a novel Bcl-2 homology domain 3-containing proapoptosis protein in the cytoplasm. J. Biol. Chem. 275:3239-3246. [PubMed] 37. Tsunematsu, R., K. Nakayama, Y. Oike, M. Nishiyama, N. Ishida, S. Hatakeyama, Y. Bessho, R. Kageyama, T. Suda, and K. I. Nakayama. 2004. Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development. J. Biol. Chem. 279:9417-9423. [PubMed] 38. Weissman, A. M. 2001. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell. Biol. 2:169-178. [PubMed] 39. Winston, J. T., D. M. Koepp, C. Zhu, S. J. Elledge, and J. W. Harper. 1999. A family of mammalian F-box proteins. Curr. Biol. 9:1180-1182. [PubMed] 40. Xu, L., Y. Wei, J. Reboul, P. Vaglio, T. H. Shin, M. Vidal, S. J. Elledge, and J. W. Harper. 2003. BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3. Nature 425:316-321. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||||
Nat Rev Mol Cell Biol. 2004 Sep; 5(9):739-51.
[Nat Rev Mol Cell Biol. 2004]Nat Rev Mol Cell Biol. 2001 Mar; 2(3):195-201.
[Nat Rev Mol Cell Biol. 2001]Nat Rev Mol Cell Biol. 2001 Mar; 2(3):169-78.
[Nat Rev Mol Cell Biol. 2001]Annu Rev Biochem. 1998; 67():425-79.
[Annu Rev Biochem. 1998]Oncogene. 2004 Mar 15; 23(11):2037-49.
[Oncogene. 2004]J Virol. 1992 Mar; 66(3):1752-60.
[J Virol. 1992]J Virol. 2004 Mar; 78(6):2749-57.
[J Virol. 2004]J Biol Chem. 2000 Feb 4; 275(5):3239-46.
[J Biol Chem. 2000]Proc Natl Acad Sci U S A. 2002 Dec 24; 99(26):16601-6.
[Proc Natl Acad Sci U S A. 2002]Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):9855-60.
[Proc Natl Acad Sci U S A. 2003]Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):9855-60.
[Proc Natl Acad Sci U S A. 2003]Nat Genet. 2005 Oct; 37(10):1119-24.
[Nat Genet. 2005]Genes Dev. 2001 Oct 15; 15(20):2642-7.
[Genes Dev. 2001]Cell. 1996 May 31; 85(5):707-20.
[Cell. 1996]EMBO J. 2000 May 2; 19(9):2069-81.
[EMBO J. 2000]J Biol Chem. 2004 Mar 5; 279(10):9417-23.
[J Biol Chem. 2004]J Biol Chem. 2004 Mar 5; 279(10):9417-23.
[J Biol Chem. 2004]Cell. 1996 May 31; 85(5):707-20.
[Cell. 1996]Nat Cell Biol. 2004 Dec; 6(12):1229-35.
[Nat Cell Biol. 2004]Proc Natl Acad Sci U S A. 1999 Mar 30; 96(7):3859-63.
[Proc Natl Acad Sci U S A. 1999]EMBO J. 2000 May 2; 19(9):2069-81.
[EMBO J. 2000]J Biol Chem. 2004 Mar 5; 279(10):9417-23.
[J Biol Chem. 2004]Nat Cell Biol. 2004 Dec; 6(12):1229-35.
[Nat Cell Biol. 2004]Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):9855-60.
[Proc Natl Acad Sci U S A. 2003]Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):9855-60.
[Proc Natl Acad Sci U S A. 2003]Dev Biol. 2002 Oct 15; 250(2):358-73.
[Dev Biol. 2002]Nat Rev Genet. 2001 Jul; 2(7):538-48.
[Nat Rev Genet. 2001]Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):9855-60.
[Proc Natl Acad Sci U S A. 2003]Nat Genet. 2000 Jul; 25(3):311-4.
[Nat Genet. 2000]Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):9855-60.
[Proc Natl Acad Sci U S A. 2003]Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):9855-60.
[Proc Natl Acad Sci U S A. 2003]Proc Natl Acad Sci U S A. 2002 Dec 24; 99(26):16601-6.
[Proc Natl Acad Sci U S A. 2002]Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):9855-60.
[Proc Natl Acad Sci U S A. 2003]Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):9855-60.
[Proc Natl Acad Sci U S A. 2003]Proc Natl Acad Sci U S A. 2002 Dec 24; 99(26):16601-6.
[Proc Natl Acad Sci U S A. 2002]Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):9855-60.
[Proc Natl Acad Sci U S A. 2003]J Biol Chem. 2000 Nov 17; 275(46):35661-4.
[J Biol Chem. 2000]Cell. 2003 Jan 10; 112(1):29-40.
[Cell. 2003]Mol Cell Biol. 2005 Jul; 25(13):5579-89.
[Mol Cell Biol. 2005]J Biol Chem. 2001 May 4; 276(18):14537-40.
[J Biol Chem. 2001]Nat Genet. 2005 Oct; 37(10):1119-24.
[Nat Genet. 2005]Nat Genet. 2005 Oct; 37(10):1119-24.
[Nat Genet. 2005]J Biol Chem. 2000 Feb 4; 275(5):3239-46.
[J Biol Chem. 2000]Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):9855-60.
[Proc Natl Acad Sci U S A. 2003]Dev Biol. 2002 Oct 15; 250(2):358-73.
[Dev Biol. 2002]Placenta. 2005 Apr; 26 Suppl A():S3-9.
[Placenta. 2005]Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):9855-60.
[Proc Natl Acad Sci U S A. 2003]J Virol. 2004 Mar; 78(6):2749-57.
[J Virol. 2004]J Virol. 1992 Mar; 66(3):1752-60.
[J Virol. 1992]J Biol Chem. 2000 Feb 4; 275(5):3239-46.
[J Biol Chem. 2000]